We would love to hear your thoughts about our site and services, please take our survey here.
Hello Bigtosh, I did take a £1000 profit at 713p just in case the slide continued but my Mother has plenty remaining but is not of an age for waiting longterm. Thanks for your take on the hardware. Ukraine has surely caused a shake up with the software and shrinking of the total addressable market for visa and mastercard and will have to see how fintech reacts and the response if one is required. Uncertainty is a killer for SPs.
The point for me Monty, and I know it does not reflect on the bottom line in results yet, is that the savings in time and energy should see Blackbird forced on all reporters in the field and the only reason it isn't is inertia and strong loyalty to existing workforce in head offices which would/should be chopped. Could also be editorial control plays a part. Maybe a new more egalitarian set up for ownership combined with Blackbird will emerge to dominate rather than selling to existing players.
https://www.otcmarkets.com/stock/POYYF/quote
£3.41
https://www.otcmarkets.com/stock/AUCOY/quote
£3.45
Does it keep them off the TO? and consequently increases the likelihood of a rise in SP for iis to sell into as they don't want the dividend. The ceo strategy is rather opaque it seems to me as I cannot imagine stock on loan so big being devoid of ceo contact of some sort.
$500 promised is worth 76p dividend if no take up of TO . SP would reduce to 138p on todays reaction which seems to assume the $500m is in the price already - Market Cap would then be £683m. Seems to me the best play is to wait for the dividend and then see where the SP settles as would hope it would be higher than 138p.
Good points and answers my previous post on acquiring custom. The public interface is not GB forte maybe but obviously the crucial element for innovation even if transaction analysis is also required to confirm a likely fraud which is GB forte I think and often perpetrated online maybe. Results will be informative.
It is easy for GBG to buy up, evidently, but it makes me suspicious that maybe they could have poached the customers easily enough or maybe that is a difficult thing to do in IDV. At least the market is favourable towards the latest deal.
https://www.lse.co.uk/rns/GBG/acquisition-of-verifi-identity-solutions-limited-7zypoaf3ji3v63s.html
Just win the science battle, you can't get back the money wasted/being wasted. AVCT is best positioned to do this, Mologic has sold out. I would have thought a cohort of 100 taking AffiDX/Meduflow every day would prove very interesting re Omicron. A positive could be compared with Flowflex on the same day and for days thereafter until both negative- comparative analysis. Don't tell me volunteers at say £20/day to participate would be short on the ground and results guaranteed currently.
https://www.flowflexrapidtest.com/wp-content/uploads/2021/03/Clinical-Study-Report.pdf
No, Boris has been misadvised and the Surescreen test is Innova all over again, the Government being done over as Innova shut down but Flowflex is another Chinese test gaming the system. The Innova Welsh factory-what happened to that? Perhaps they picked up a trick or two by example or even advice, after all Innova factory rather discredited? The MO for Surescreen is very similar and it is the taxpayer paying and Boris is powerless. They have negotiated PD so can sell a test probably not as good as AffiDX which PCR cannot measure for efficacy as it does not detect the infectious state of the virion nucleocapsid, no problem. Brain+use=solution.
None of them do rigorous research, aka, work- they have been gifted a brain but it is used to deflect and discombobulate, PIs here have absorbed evidence that points to bad science, MPs probably don't know what frozen spiked samples/Cobas 6800/PCR Ct/earlier detection and isolation to reduce R rate constitutes in scientific knowledge so procedure at PD remains unchallenged.
Cummings would have looked into the failure of approval but a bunch of incompetents took over when No 10 warfare saw him ousted (but still involved with covid though without effect) due to probably an anti climate change attitude. Whether he could have had any effect on Bell I don't know but AS and the consortium would have been in the loop when it had that Northern composition. Bell/Whitty/Han-co-ck/Whitty/Peto/big pharma/Oxford were too compromised by their connections to challenge Bell and his Chinese sanction.
No celebration due over David Evans whistle blowing. A change in procedure at PD is the only thing to celebrate.
AS is currently doing a comparative LFT study (why do they take so long-perhaps over thorough). It may be my ego but I think I was the first to call out PD procedures and suspect frozen samples as the culprit. An amateur with a scientific bias in thinking and a highly ethical viewpoint; I see the corruption in pharma as previously mentioned and its reach into the establishment as a barrier for AS which can only be surmounted by the adoption of affimers providing an income stream. It does not matter where this happens.
I note the Chinese have the largest patents for climate mitigating to offset pollution which the west are hot on doing- they see how they can exploit the system. Bell has been blinkered as someone who exploits the system himself so has a blind spot to the Chinese who have got their test on the market via greedy chancers. The Government are not accountable for this system failure at the moment but Brexit was their chance to clean up by decoupling from Roche and the EU and they can still do it. I will be voting for the loony party if changes are not made as at the moment there is active pilfering of taxes.